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Abstract: Emotional processing, particularly facial expression recognition, is essential for social
cognition, and dysfunction may be associated with poor cognitive health. In pathological ageing con-
ditions, such as mild cognitive impairment (MCI) and Alzheimer’s disease (AD), in which cognitive
impairments are present, disturbed emotional processing and difficulty with social interactions have
been documented. However, it is unclear how pathological ageing affects emotional processing and
human social behaviour. The aim of this study is to provide insight into how emotional processing is
affected in MCI and AD and whether this capacity can constitute a differentiating factor allowing
the preclinical diagnosis of both diseases. For this purpose, an ecological emotional battery adapted
from five subsets of the Florida Affect Battery was used. Given that emotion may not be separated
from cognition, the affect battery was divided into subtests according to cognitive demand, resulting
in three blocks. Our results showed that individuals with MCI or AD had poorer performance on
the emotional processing tasks, although with different patterns, than that of controls. Cognitive
demand may be responsible for the execution patterns of different emotional processing tests. Tasks
with moderate cognitive demand are the most sensitive for discriminating between two cognitive
impairment entities. In summary, emotional processing tasks may aid in characterising the neurocog-
nitive deficits in MCI or AD. Additionally, identifying these deficits may be useful for developing
interventions that specifically target these emotional processing problems.
Keywords: emotional processing assessment; diagnosis; mild cognitive impairment; Alzheimer’s disease
1. Introduction
Emotional processing, particularly facial expression recognition, is essential for social
cognition with clear and direct involvement in adequate human social behaviour [1].
Difficulties in processing emotional signals might have important implications for social
interactions throughout life and are associated with low social competence and a poor
social life ([2], reviewed in ref. [3]). Having a range of good social connections has been
identified as an important aspect of successful ageing [4]. Conversely, impaired emotional
processing is associated with specific reductions in social competence and interpersonal
functioning [5–7], which may lead to social isolation and psychopathological disorders [8].
However, emotion may not be separated from cognition [9]. In fact, social isolation has
been associated with deficient cognitive health [10,11].
In pathological ageing conditions, such as mild cognitive impairment (MCI) and
Alzheimer’s disease (AD), in which cognitive impairments are present [12–14], disturbed
emotional processing and difficulty with social interactions have been documented [15,16].
Neuropsychiatric and behavioural symptoms such as agitation, wandering, and aggression
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have been linked to impaired emotional processing, particularly to deficits in the ability to
perceive and recognise the emotions of others. These behavioural impairments are common
in patients with Alzheimer’s dementia [8]. However, it is unclear how pathological ageing
affects emotional processing and human social behaviour. In this sense, it has been reported
that AD patients have more severe impairments in emotion perception than patients with
MCI and healthy older adults [16–19], while other studies show that people with AD have
no deficits in emotional perception compared to controls [20–22].
Furthermore, the emotional processing deficit in MCI is very controversial [23–25].
MCI refers to a state of cognitive function that is abnormal for a person’s age and education
level but does not meet criteria for clinically probable AD. However, some individual
diagnosis of MCI may progress to AD [14,26,27]. Although not entirely conclusive, it
has been suggested that facial emotion processing can be impaired in MCI prior to more
marked cognitive deficits [20]. Most of the studies aimed at the neuropsychological charac-
terisation of these conditions have focused on cognitive deficits, nevertheless, an emotional
processing assessment may enable a more comprehensive and in-depth knowledge of
the impairment profile in both MCI and AD. Understanding the first signs of emotional
processing deficits is of great clinical significance because it specifically allows different
strategies for prevention and intervention. In addition, it would be of great interest to be
able to detect discrete cognitive impairment through some type of neuropsychological
evaluation in order to start treatment as soon as possible, but no test with a high predictive
value for the development of AD has been described so far.
The aim of this study is to provide further insight into how emotional processing
is affected in MCI and AD compared to senior healthy controls. To this end, we used
an ecological emotional battery adapted from five subsets of the Florida Affect Battery
(FAB) [28–31]. This battery enables the assessment of emotional processing in different
sensory modalities, including prosody and facial discrimination. This type of neuropsy-
chological test would be a good predictive tool, both because of its low economic cost and
its usefulness in routine clinical practice since it is easy to apply and is not influenced by
one’s academic level. According to this idea, in a previous investigation we found that
the decline in the task of categorising facial expression is more evident in a subgroup of
Parkinson’s patients with greater global impairment (motor and cognitive) [32].
Conversely, cognitive demands can influence the execution of different emotional
processing tests, particularly mnemonic and linguistic functions. In this sense, semantic
memory may be impaired in clinically recognized states of cognitive impairment such
as MCI and AD [33]. Moreover, language performance deficits can appear early before
impairment in episodic memory, visuospatial construction ability, or mental status in
individuals at risk for MCI [34]. In the same sense, AD is associated with a loss of semantic
knowledge [35] and grammatical comprehension [36]. For this reason, the affect battery
was divided into subtests according to cognitive demand that resulted in three blocks.
According to the abovementioned evidence, we expected that patients exhibiting either
cognitive impairment entity, MCI or AD, would display emotional processing difficulties
at varying levels of intensity. Thus, while participants with MCI would exhibit a slight but
noticeable and measurable decline in emotional processing, AD participants would have a
clear impairment. These deficits will be more evident when emotional tasks that require
high memory and language load are performed.
2. Material and Methods
2.1. Sample
The sample comprised 101 individuals (33 males and 68 females) aged between 67
and 95 years (M = 81.93, SD = 6.28). A total of 45 were healthy control elderly individ-
uals, 24 were patients with MCI, and 32 were patients with moderate AD. Participants
were recruited from senior day centres, from nursing homes, via family caregivers of
people with Alzheimer’s disease or from their own homes within the provinces of Malaga,
Cádiz, Madrid and Valencia (Spain). All participants were able to follow instructions
Int. J. Environ. Res. Public Health 2021, 18, 2770 3 of 14
and understand the content of the assessment through verbal communications. Exclusion
criteria included cases with disturbance of consciousness, delirium, psychiatry disorders,
challenging behaviour, severe physical illness, and severe aphasia of a major sensori-
motor impairment. The diagnosis of MCI was based on Petersen’s criteria (reviewed in
ref. [37]), and a probable diagnosis of AD was based on the Diagnostic and Statistical
Manual of Mental Disorders (4th ed.) (DSM-IV) and the National Institute of Neurologi-
cal and Communicative Disorders and Stroke and the Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA) criteria. All diagnoses were established by an
experienced physician.
To describe and compare groups regarding age, depression, independence with respect
to activities of daily living, and general cognitive status, we compared age and scores on
the Geriatric Depression Scale (GDS-15, [38]), the Barthel index activities of daily living,
and the Spanish version of the Mini-Mental Status Examination (MMSE-S, [39,40]). In
the Spanish version, scores range from 0–35 instead of from 0–30. Scores higher than
30 indicate basically no cognitive impairment, scores between 25 and 29 indicate mild
cognitive impairment, and scores less than 24 indicate cognitive impairment. The results
are shown in Table 1. No differences among groups were observed in age, GDS-15 scores,
or Barthel index scores. However, differences among groups on MMSE-S scores support
higher cognitive impairment in the AD group, mild cognitive impairment in the MCI group,
and no cognitive impairment in the control group. In fact, scores from all participants from
the control group on the MMSE-S indicated no impairment.
Table 1. Characteristics of the control, mild cognitive impairment (MCI) and Alzheimer’s disease
(AD) groups according to age and scores on Geriatric Depression Scale (GDS-15), the Barthel index




M (SD) M (SD) M (SD)
Age 80.76 (6.59) 83.00 (5.58) 82.78 (5.42) 1.44
GDS-15 3.46 (2.70) 4.38 (3.06) 4.16 (2.09) 1.19
Barthel Index 77.78 (28.78) 75 (26.94) 68.13 (29.69) 1.08
MMSE-S 32.49 (1.53) 27.17 (1.58) 18.72 (3.15) 370.75 *** C vs. MCI; C vs. AD;MCI vs. AD
Note. *** p < 0.001.
2.2. Procedure
The study protocol was carried out following the rules of the Declaration of Helsinki
of 1975 and approved by the Research Ethics Committee of Malaga University (CEUMA:
2014-0005-H). All participants or legally authorised representatives provided informed
consent according to the declaration of Helsinki and the Spanish law on personal data
protection (RD 1720/2007 and Organic Law 3/2018, of 5 December, on Data Protection and
Guarantee of Digital Rights).
The research team contacted different senior day centres, nursing homes, and as-
sociations for families of people with Alzheimer’s and other dementias in the province
of Malaga, Cádiz, Madrid, and Valencia (Spain) and informed them about the study’s
objectives and procedures. Individuals from the institutions and associations that agreed
to participate were invited to take part in the study, and those who agreed to participate
completed the questionnaires (MMSE-S, GDS-15, Barthel index, and FAB). The tests were
administered in two or three different sessions, lasting approximately one hour, separated
by between 1 and 3 days, in the same room, for every subject. The number of sessions
depended on the physical and/or cognitive status of the participants to avoid the pos-
sibility that fatigue could bias the results. The cognitive evaluation was carried out by
experienced psychologists belonging to the staff of each of the centres and following a
standardised protocol.
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After completing the MMSE-S, GDS-15 and Barthel index tests, each subject individu-
ally performed a computerised battery of 13 tasks (for a more detailed description, please
see Carvajal et al. 2007 and 2009). For this purpose, participants were seated at approxi-
mately 50 cm from a 17.3 in. 1.920 × 1.080-pixel computer screen. The order of presentation
of tasks was counterbalanced. All the tests of emotional battery were administered by a
trainer psychologist (JC).
2.3. Instruments
For the emotional processing assessment, all participants performed a computerised
battery of tests composed of 13 tasks that require discrimination, recognition, and recall
of facial emotions. These tasks, which have been used in several clinical studies, were
adapted [28–32] from 5 subsets of the FAB [41]. This version is shorter than the original
battery (which makes it easier to apply to a population with cognitive impairment). Differ-
ent from the original, it includes a block of immediate and deferred memory tasks for faces,
emotional facial expressions, and verbal emotional memory [31], which can be especially
useful for evaluating pathologies affecting memory [29–31]. It also uses a discrimination
task based on the paradigm «a face-in-the-crowd effect» [28], and the prosody test has been
adapted to the Spanish-speaking population [30,42].
The battery was divided into three blocks according to cognitive demand. Tasks
grouped in the first block included discrimination and facial emotion recognition tasks
without the involvement of relevant grammatical and semantic aspect language. Tasks
grouped in the second block included discrimination and facial emotion recognition tasks
with the involvement of relevant grammatical and semantic aspects, including denomina-
tion, the classification and valence of facial emotional expression, and prosody identifica-
tion. Finally, the tasks grouped in the third block included tasks of declarative memory,
i.e., immediate and deferred memory for emotion-laden words and for emotional facial
expressions and two recognition memory tasks of face identity and emotion. Table 2 shows
a more detailed description of the tasks of each block.
Table 2. Tasks which compose the ecological emotional battery adapted from five subsets of the Florida Affect Battery (FAB).
Block Task Description
Block 1. Discrimination tasks
Matrices
Facial identity and emotional expression discrimination
in a task using the paradigm «a face-in-the-crowd effect»
Range of score: 0–60
Facial Discrimination Task
(subtest 1 of the FAB)
Subjects had to decide whether the photographs
were of the same person or not.
Range of score: 0–10
Facial Affect Discrimination Task
(subtest 2 of the FAB)
Participants had to decide whether the faces showed the
same or different emotional expressions.
Range of score: 0–15
Block 2. Discrimination and
selection tasks (with a clear
language participation)
Facial Affect Naming Task
(subtest 3 of the FAB)
Participants had to choose from emotional word
categories (and intensity) that best corresponded to the
expression in the photograph.
Range of score:0–15
Emotional Labelling
Participants had to labelling emotional
facial expressions.
Range of score: 0–15
Facial Affect Selection Task
(subtest 4 of the FAB)
From five photographs of each screen, the participants
had to select which of the five photographs displayed
the indicated emotion.
Range of score: 0–10
Prosody
Participants had to decide if there is affective
congruence between sound and meaning of sentences.
Range of score: 0–9
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Table 2. Cont.
Block Task Description
Block 3. Memory tasks.
Recall of face identity
(subtest 5 A of the FAB)
Participants had to identify the photograph that showed
the identity they had seen before, regardless of the facial
expression of the model.
Range of score: 0–10
Recall of face emotion
(subtest 5 B of the FAB)
Participants had to identify the photograph that showed
the same facial expression they had seen before,
regardless of the identity of the model.
Range of score: 0–10
Immediate emotional verbal
memory (Verbal S-T)
Participants had to remember which emotional word
was associated with a neutral word, immediately after
its presentation.
Range of score: 0–18
Deferred emotional verbal memory
(Verbal L-T)
Participants had to remember which emotional word
was associated with a neutral word, 10 m after
its presentation.
Range of score: 0–6
Immediate facial emotional
expression memory (Facial S-T)
Among 18 pictures, participants had to choose which six
had been seen before (same emotion and identity),
immediately after its presentation.
Range of score: 0–18
Deferred facial emotional
expression memory (Facial L-T)
Among 18 pictures, participants had to choose which six
had been seen before (same emotion and identity), 10 m
after its presentation.
Range of score: 0–6
Note: Verbal S-T = verbal short-term memory; verbal L-T = verbal long-term memory; facial S–T = short-term memory for facial emotional
expressions; and facial L-T = long-term memory for facial emotional expressions.
2.4. Statistical Analysis
To examine emotional differences among groups (control, MCI, and AD groups), a
series of one-way analysis of covariance with age as covariate (ANCOVA) and analyses of
variance (ANOVA) was performed for the score on each task associated with emotional
processing. The only statistically significant correlation found was between age and the
score on the emotional labelling task, therefore, we performed an ANCOVA only for
this variable. Since ANOVA is robust against non-normality [43], we focused on the
homogeneity assumption. We followed the guideline proposed by Blanca et al. (2018) [44]
regarding the control of Type I errors with respect to heterogeneity of variance with an
unbalanced design. This guideline considers the variance ratio, the coefficient of group
size variation, and the pairing between variance and group size. Measures of association
size were reflected in eta squared (η2) values. The analyses were followed by multiple
comparisons between groups with Bonferroni adjustment when required.
3. Results
Ten participants showed a missing value in at least one of the dependent variables.
The Little’s test of missing completely at random did not reach statistical significance,
χ2 (93) = 77.23; p = 0.88, indicating that missing values were randomly distributed across
all observations. Therefore, we proceeded with the analysis using completed cases for
each variable. The results from the ANCOVA and ANOVA series are shown in Tables 3–5.
According to Blanca et al. (2018), in an unbalanced design, ANOVA controls Type I
errors when the variance ratio is equal to or less than 1.5. This was the case for six of
the 13 dependent variables. Of these remaining cases, five variables showed variance
ratios between 1.6 and 3, but the pairing between variance and group size supported
ANOVA robustness. Finally, 2 cases showed variance ratios between 4 and 6, but again,
the pairing between variance and group size, considering the coefficient of group size
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variation, ensured the control of Type I errors. Based on these results, we considered it
appropriate to proceed with the interpretation of the results from the statistical analysis.
Table 3. Emotional processing in tasks that do not require a relevant involvement of grammatical and semantic aspects of
language. Mean (M) and standard deviation (SD) of the dependent variables according to diagnosis, and F-statistics from
ANOVA and eta squared.
Variables
Control MCI AD
F p η2 Comparisons
M (SD) M (SD) M (SD)
Matrices 41.82 (9.88) 37.7 (11.22) 34.80 (11.22) 4.06 0.02 0.08 C vs. AD
FAB 1 9.04 (1.40) 8.96 (1.40) 7.75 (1.72) 7.71 <0.01 0.14 C vs. AD; MCI vs. AD
FAB 2 11.36 (1.78) 10.46 (2.81) 10.84 (1.93) 1.52 0.22 0.03
Note. n (control, MCI, AD): Matrices: 45, 24, 30; FAB 1: 45, 24, 32; FAB 2: 44, 24, 32.
Table 4. Emotional processing in tasks that require a relevant involvement of grammatical and semantic aspects of language.




F p η2 Comparisons
M (SD) M (SD) M (SD)
FAB 3 9.38 (2.41) 9.30 (2.18) 8.20 (2.48) 2.44 0.09 0.05
Labelling 8.62 (2.14) 8.67 (2.75) 7.51 (1.87) 3.25 0.06 0.06
FAB 4 7.41 (1.64) 6.46 (1.66) 6.55 (1.63) 3.67 0.03 0.08 C vs. MCI; C vs. AD a
Prosody 3.72 (1.81) 3.32 (1.46) 2.63 (1.35) 4.16 0.02 0.08 C vs. AD
Note. n (control, MCI, and AD): FAB 3: 45, 23, 30; Labelling: 45, 24, 30; FAB 4: 44, 24, 31; Prosody: 44, 22, 30. a one-tailed Bonferroni adjustment.
Table 5. Tasks that involved a high load of immediate and deferred memory for emotion-laden words and for emotional
facial expressions. Mean (M) and standard deviation (SD) of the dependent variables according to diagnosis, F-statistics
from ANOVA and eta squared.
Variables
Control MCI AD
F p η2 Comparisons
M (SD) M (SD) M (SD)
FAB 5 A 7.18 (2.09) 5.79 (1.95) 5.50 (2.20) 6.82 <0.01 0.12 C vs. MCI; C vs. AD
FAB 5 B 4.58 (1.98) 3.50 (1.91) 3.40 (1.32) 4.93 <0.01 0.09 C vs. AD
Verbal S-T 3.82 (3.30) 2.13 (2.62) 0.84 (1.60) 11.20 <0.01 0.19 C vs. MCI; C vs. AD
Verbal L-T 1.11 (1.31) 0.58 (0.76) 0.15 (0.51) 8.63 <0.01 0.15 C vs. AD
Facial S-T 9.42 (2.92) 8.04 (3.27) 5.72 (3.54) 12.41 <0.01 0.20 C vs. AD; MCI vs. AD
Facial L-T 3.36 (1.41) 2.21 (1.25) 1.90 (1.62) 10.49 <0.01 0.18 C vs. MCI; C vs. AD
Note. n (control, MCI, and AD): FAB 5 A, B: 45, 24, 30; Verbal S-T, L-T, and Facial S-T: 45, 24, 32; Facial L-T: 44, 24, 30.
3.1. Emotional Discrimination That Does Not Require the Involvement of Relevant Grammatical
and Semantic Aspects of Language (Block 1)
Regarding the matrices task, the results revealed significant differences among groups
in face and emotional facial discrimination task performance using the paradigm “a face-in-
the-crowd effect” proposed by Hansen and Hansen (1988) [45]. Post hoc analysis indicated
that AD participants exhibited more problems and had less accuracy in finding faces
based on identity and/or facial expressions than older people without cognitive deficits.
However, there were no differences between the control and MCI groups.
In the facial discrimination task (subtest 1 of the FAB), significant differences were
observed among groups, showing that individuals with AD had difficulty discriminating
facial identity compared to the performance by individuals in the MCI and control groups.
Again, the results from individuals with MCI did not differ from those of the control group.
Conversely, ANOVA results indicated that cognitive impairment did not affect performance
on the facial affect discrimination task (subtest 2 of the FAB) (please see Table 3).
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3.2. Emotional Discrimination That Requires the Involvement of Relevant Grammatical and
Semantic Aspects of Language (Block 2)
The results revealed no differences among groups regarding the facial affect naming
task (subset 3 of the FAB) and the emotional labelling task. There were differences in the
Prosody task performance, showing that the AD group experienced difficulties on both
tasks compared to the results of the control group.
Finally, in relation to the facial affect selection task (subtest 4 of the FAB), in which
the participant had to select the photographs with the displayed emotion indicated by
the experimenter, and significant differences were observed among groups, revealing
significant differences between controls and individuals exhibiting either MCI or AD
(please see Table 4).
3.3. Tasks That Involved a High Load Declarative Memory (Block 3)
Overall, the results support a decline in recognition memory in MCI and AD. Statistical
analysis revealed that the average recognition error rates for the facial identity recall task
(subtest 5A of the FAB) were greater for subjects with cognitive impairments (MCI and
AD). Similarly, participants with cognitive impairments made significantly more errors
than the control group on the recall of face emotions task (subtest 5B of the FAB).
Regarding emotional verbal memory, the results indicated significant differences
among groups in scores on the immediate emotional verbal memory task (verbal S-T),
showing that the AD and MCI groups had lower scores than the control group. Differences
were also found in scores on the deferred emotional verbal memory task (verbal L-T) but
only between the AD and control groups.
Finally, in relation to memory for facial emotional expression, the results showed that
the immediate facial emotional expression memory task (facial S-T) was only impaired in
AD. Nevertheless, the deferred facial emotional expression memory task (facial L-T) results
differed in both the MCI and AD groups compared to those of the control group (please
see Table 5).
4. Discussion
Determining sensitive assessment tools for detecting neuropsychological changes is
crucial for the early identification of MCI and AD. Most research has focused on assessing
cognitive functions but evaluating emotional processing may also be a sensitive way to
achieve a better characterisation of the clinical profile of both entities, which may entail
better implementation of effective strategies for slowing the decline of cognitive and social
abilities [19]. Hence, this study was designed to examine how emotional processing is
affected in MCI and AD. For this purpose, we used an ecological emotional battery adapted
from five subsets of the Florida Affect Battery (FAB). Given that emotional processing
may be influenced by concurrent cognitive demand [46], the battery tasks were grouped
into three blocks. Cardinal MCI and AD symptoms are memory impairments [33,47] and
linguistic function decline [34,35]. For this reason, the tasks were grouped considering
whether semantic and grammatical, mnemonic, or none of these cognitive functions were
directly and mainly involved. This battery, in addition to being ecological and adapted
to the Spanish-speaking population, is composed of a wide range of tasks including not
only face recognition and discrimination tests and emotional labelling, but also valence,
prosody, and memory tests for facial expressions. This wide range of tasks can help to
better characterise emotional disturbances in older populations with cognitive impairment
such as AD and MCI.
In the emotional battery, considering results from the discrimination task that do
not require a clear involvement of grammatical and semantic aspects of language, the
AD group showed poorer performance on the discrimination of facial identity (facial
discrimination task). Nevertheless, the ability to discriminate facial emotions was relatively
preserved depending on the complexity of the task. Similar to what has been observed
by other authors, AD participants had difficulty discriminating facial emotions when a
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complex task that assessed “a face-in-the-crowd effect” (matrix) was used [15], but not
with a simpler facial affect discrimination task that required the participant to indicate
whether a pair of faces depicted the same or a different emotion [15,19]. These results
differ from those found using the same version of the affect battery in patients with
degenerative disease (dementia associated with Parkinson’s disease). These data would
reveal that possibly different neurobiological substrates may be responsible for these
effects. Thus, the problems found in facial expression recognition may be associated with
the progressive neuronal loss in frontostriatal and mesolimbic circuits, which characterises
Parkinson disease [30]. However, the MCI group did not show any impairment in facial and
emotional discrimination. Together, these results revealed that in AD patients, facilitation
elicited by emotional content was observed when a simple discrimination task was used.
Nevertheless, this population showed problems with discrimination identity, and partially,
facial emotions, despite the tasks not requiring a high memory load or semantic and
grammatical aspects of language. Deficits in visual tasks are also commonly reported in
AD [48]. However, impairment in discrimination tasks may not be attributed unequivocally
to perceptual processes. In fact, AD patients were partially able to distinguish between
different static facial expressions when the complexity of the task was reduced. Matching
tasks such as matrices and subtest 1 of the FAB used involve many processes (attention,
motor response, decision making, among others), contributing to performance [49]. Given
that AD patients usually have poor general cognitive functioning beyond linguistic or
mnemotechnic difficulties, cognitive problems such as attention, decision making, or
working memory may explain this deficit, at least in part, because emotional facilitation of
face discrimination was not observed during the complex affect discrimination task. These
alterations observed in AD patients that were not seen in MCI may be due, at least in part,
to greater temporal lobe degenerative involvement. In this sense, with the aim of deepening
the understanding of this circuitry underlying emotional processing we have also carried
out an extensive study with patients with temporal lobe epilepsy with unilateral resection
of the hippocampus and amygdala [28,29]. Our findings indicate that there is a dissociation
between processing facial identity and facial expression, and a clear involvement of the
temporal lobe and a degree of functional and hemispherical specialisation. Collectively, AD
participants, unlike controls or MCI participants, had problems with discrimination tasks,
and emotional facilitation was observed in a simple facial emotion discrimination task.
Then, the implications of language’s role in emotional processing were also explored.
Participants were asked to match a range of facial emotional expressions with the name
(or value) of the presented valence and intensity (facial affect naming task, subtest 3 of the
FAB). It has been considered that an approach based on the intensity of emotions can be
more sensitive to detecting subtle deficiencies in facial emotion recognition. However, very
few studies take into account the intensity of emotions [50]. In consonance with prior stud-
ies indicating intact emotional ratings in AD [51–53], the results revealed an unimpaired
capacity to match the emotional valence or intensity of facial expression with the name pre-
sented. Both MCI and AD participants performed these tasks at the same level as controls
in rating the emotional descriptions for valence and arousal. Therefore, the intensity of
facial expressions has not helped to discriminate between clinical populations. Alterations
in mood could be a factor affecting results, but this possibility has to be ruled out as no
differences between the groups were observed in the GDS-15 test. However, regarding
language skills, different from what Bucks and Radford (2004) found with prosody tasks
of Florida Affect Battery [19], AD participants have problems related to understanding
prosody, exhibiting difficulty in prosody-emotional sentence matching tasks. Cultural
differences may explain, at least partially, the discrepancies between studies. However,
it has been described that processing information relating to affective tone and impaired
prosody comprehension impairments occur early in the disease course and remain stable
as cognitive function declines [36]. This task has been particularly sensitive to damage
to the left hippocampus. Patients with left temporal lobectomy showed impairment in
discriminating facial expressions, in the memory of a facial expression, and/or in nam-
Int. J. Environ. Res. Public Health 2021, 18, 2770 9 of 14
ing facial expressions [29]. In HIV+ individuals, a strong association between lower left
hippocampus volumes and poorer test scores was found [30], which may be due to the
demands of the task of matching emotional prosody to visual faces. Affective prosody is
a powerful signal for social communication therefore, loss of affective-prosodic compre-
hension may have an impact on social relationships [54]. Furthermore, AD participants
performed worse than the rest of the groups on emotional labelling but did not reach
statistical significance. Anomia is one of the most evident linguistic symptoms in AD,
beginning in the initial phase of the disease and becoming particularly pronounced on
visual confrontation naming tasks [55], including emotional labelling [24]. Anomia may be
related to the inability of a patient to access the phonological label for a particular word, and
over the course of the disease, it may reflect a semantic knowledge disruption. It has been
documented that impaired access to the meaning of emotion-related words impairs the
ability to perceive emotions on faces [56], which may explain, at least partially, emotional
discrimination problems observed in AD. However, problems to remember names, things,
and places are a frequent complaint of older people and they often fail to form association
between faces and names or to recall names from faces [57]. Thus, during this period of
life, difficulties can be observed between the association of a name and a face (based on
facial identity) [58,59]. Older people are also less accurate in labelling the facial expressions
of some emotions [60]. It could therefore be that they also have difficulty in associating
an emotional facial expression with the corresponding name. These difficulties could also
explain why, although there is a clear deterioration in Alzheimer’s, no differences have
been observed between the different groups. This could be investigated in the future. On
the other hand, AD participants did not have problems selecting a verbal category from
a given facial expression. Moreover, by using naming tests, subjects with AD benefited
from phonemic cues [61] suggesting that the labelling and emotional facial discrimination
difficulties observed in individuals with moderate AD may not be completely explained by
semantic problems.
On the other hand, MCI and AD participants had difficulty selecting one of the five
photographs that displayed the emotion indicated by the experimenter (facial affect selec-
tion task, subtest 4 of the FAB). Given that participants with MCI had not demonstrated
problems in emotional labelling, other cognitive functions besides impaired language
should not be ruled out. In subtest 4 of the FAB, beyond the ability to assign a name to
a facial expression, attention and working memory, including decision making, with a
clear involvement of language, are required. Both the MCI and AD groups displayed
impaired attentional processing and working memory capacity [62–65], which may explain
the observed deficits in performance on this task. Along the same lines, problems in facial
expression recognition task of subtest 4 of the FAB, which have also been found in neu-
rocognitively affected HIV+ patients, but not in patients without cognitive impairment [30].
Together, when there is clear language involvement in emotional processing, emotional
labelling and prosody comprehension may be more useful to distinguish between MCI
and AD neuropsychological impairments. Otherwise, the simplest (FAB3) or complex task
(FAB4) is not effective in discriminating between both entities.
Finally, the performance on emotional processing with a high explicit memory de-
mand was evaluated. For this, facial identity and emotion recall (subtest 5A and 5B of the
FAB, respectively), immediate and deferred verbal memory (for emotion-laden words),
and immediate and deferred facial emotional expression memory were assessed. Emo-
tional content enhanced recognition [66] and strength memory traces for emotion-laden
information in normal subjects, whereas for Alzheimer participants, emotions did not
benefit memory. As expected, AD participants exhibited clear memory problems. Memory
performance was the worst in the AD group irrespective of the tasks and, consistent with
most laboratory evidence, participants with AD were unable to experience declarative
memory enhancement via emotional information [66–69]. MCI patients had poor memory
overall. Our results suggest that the effects of emotion on memory were not completely
preserved in patients with MCI. Thus, immediate memory performance for emotional
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facial expressions was similar to that observed in the control group and that of immediate
and deferred emotional verbal memory was situated on the spectrum between healthy
ageing and AD individuals, while performance on identity and emotional information
recall of faces and deferred memory for emotional facial expressions was similar to that
seen in AD participants. Together, we observed that despite poor memory accuracy overall
in MCI patients, there were differences in the pattern of memory impairment with respect
to AD.
This study has certain limitations that must be acknowledged. First, the use of a
cross-sectional design means that no causal relationships can be inferred from the results.
Second, we recruited participants by means of convenience sampling, thus restricting the
generalisability of the findings. Thirdly, given the sample size, control for certain sociode-
mographic variables (e.g., sex, education) has not been included in the statistical analysis.
Fourth, the group of patients with mild cognitive impairment was not been divided by
subtypes. It would be interesting in future studies to include this information in order to
analyse its impact on emotional processing. Despite these limitations, the study makes an
important contribution. Thus, our data reveal that measuring emotional processing with
tasks that require different cognitive demands can help to better characterise deterioration
in DLB and AD. Our results showed poorer performance by the AD group compared with
that of the control group on the emotional processing tasks, except for a simple emotional
discrimination task or a task of assigning the valence and intensity of facial expressions.
Nevertheless, in the MCI group, the pattern of impairment depends on the difficulty of the
task and cognitive demand. MCI participants performed at the same level as the control
group in discrimination tasks, emotional labelling, prosody comprehension tasks, and
immediate facial emotional memory tasks and performed similarly to mild AD patients
when the tasks were more complex or required the consolidation of information. The
observed difficulties may not be explained by depression symptoms, as no differences in
GDS-15 scores were observed among groups. As expected, MCI participants had more
difficulties in tasks that required attentional processing, decision making, and working
memory capacity with a clear involvement of language or tasks with a high declarative
memory load. AD participants showed difficulties in almost all tasks regardless of whether
a high memory or language load was required.
The emotional battery employed in our study takes into account the multimodal
nature of human social relationships involving the processing of visual facial cues, the tone
of voice, the choice of words, and the memory for facial identity and emotions. In addition,
the reduced length of tasks makes it more appropriate for assessing patients with cognitive
impairment. Although emotional processing may be influenced by concurrent cognitive
demand, social cognition changes are not entirely dependent on the cognitive level and
increase over time [70]. For this reason, identifying social deficits with an ecological tool,
combined with other neuropsychological tests, can be useful as an early diagnostic test [71].
The emotional battery may improve the predictive ability of an AD risk score, combined
with other neuropsychological test scores.
Thus, these patients can benefit from a possible pharmacological and neuropsycholog-
ical intervention that modifies the evolutionary course of the disease. In this sense, in AD
patients, combined emotional rehabilitation and cognitive stimulation induced significant
improvement not only on the recognition of facial emotions, but also on processing speed,
basic activities of daily living, and scores on the Folstein Minimental Test [72].
5. Conclusions
Here, we used an ecological emotional battery adapted from five subsets of the Florida
Affect Battery. The division of this battery into three blocks according to cognitive demand
revealed that MCI participants had more difficulties in tasks that required attentional
processing, decision making, and working memory capacity with a clear involvement of
language or tasks with a high declarative memory load. AD participants showed difficulties
in almost all tasks regardless of whether a high memory or language load was required.
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Identifying emotional deficits may aid in characterising the neurocognitive deficits in
MCI or AD and may be useful for developing interventions that specifically target these
emotional processing problems.
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